Sanofi-Aventis U.S. LLC recalls

22 recalls on record · latest: April 11, 2023

Official U.S. recall history for Sanofi-Aventis U.S. LLC, compiled from official government records.

Get recall alerts

Free email alert whenever Sanofi-Aventis U.S. LLC has a new recall — straight from official government data. Unsubscribe anytime.

Admelog recalled over sterility concerns

April 11, 2023 · Drug & medication recalls Moderate risk Lack of Assurance of Sterility: Malformed crimped collar seal

Sanofi-Aventis U.S. LLC recalls Elitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Aventis U. S. LLC Bridgewater, NJ, 08807, NDC…

August 10, 2020 · Drug & medication recalls Moderate risk Failed Stability Specifications: Out of Specification result for enzyme activit…

Sanofi-Aventis U.S product recalled over manufacturing violations

October 22, 2019 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of NDMA impurity detected in product.

Regular Strength Zantac 75 mg recalled over manufacturing violations

October 22, 2019 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of NDMA impurity detected in product.

Regular Strength Zantac 75 mg recalled over manufacturing violations

October 22, 2019 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of NDMA impurity detected in product.

Zantac 150 mg recalled over manufacturing violations

October 22, 2019 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of NDMA impurity detected in product.

Regular Strength Zantac 75 mg recalled over manufacturing violations

October 22, 2019 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of NDMA impurity detected in product.

Maximum Strength Zantac 150 mg Distributed by: Chattem recalled over manufacturing violations

October 22, 2019 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of NDMA impurity detected in product.

Maximum Strength Zantac 150 mg recalled over manufacturing violations

October 22, 2019 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of NDMA impurity detected in product.

Cool Mint Maximum Strength Zantac 150 mg recalled over manufacturing violations

October 22, 2019 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of NDMA impurity detected in product.

Regular Strength Zantac 75 mg recalled over manufacturing violations

October 22, 2019 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of NDMA impurity detected in product.

Regular Strength Zantac 150 mg recalled over manufacturing violations

October 22, 2019 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of NDMA impurity detected in product.

Zantac 75 mg recalled over manufacturing violations

October 22, 2019 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of NDMA impurity detected in product.

Regular Strength Zantac 150 mg Distributed by: Chattem recalled over manufacturing violations

October 22, 2019 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of NDMA impurity detected in product.

Admelog Solostar recalled over temperature-control failures

July 5, 2018 · Drug & medication recalls Moderate risk Temperature Abuse: Product samples of Admelog may not have been shipped at prop…

Sanofi-Aventis U.S. LLC recalls Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. LLC., ND…

April 27, 2018 · Drug & medication recalls Moderate risk Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20…

Sanofi-Aventis U.S. LLC recalls Enoxaparin Sodium, Injection 120 mg/0.8 mL, pre-filled, packaged in 10-count cartons, Rx Only, Winthrop US., a business…

December 5, 2017 · Drug & medication recalls Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/…

Sanofi-Aventis U.S. LLC recalls Clofarabine injection, 20 mg/20 mL, 20 mL Single-Use Vial, Rx only, Mfd by: Teva Pharmachemle, Swensweg 5, Haarlem, The…

October 13, 2017 · Drug & medication recalls Labeling: Incorrect or Missing Package Insert: authorized generic product was p…

Sanofi-Aventis U.S. LLC recalls Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-coun…

June 12, 2017 · Drug & medication recalls Superpotent Drug: high out-of-specification result for magnesium.

Sanofi-Aventis U.S. LLC recalls Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation…

September 1, 2016 · Drug & medication recalls Labeling: Incorrect or Missing Package Insert

Sanofi-Aventis U.S. LLC recalls Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.3 mg (a) 2 prefilled auto injectors + 1 trainer (NDC 0025-5833-02)…

October 28, 2015 · Drug & medication recalls High risk Defective Delivery System; potential to have inaccurate dosage delivery

Sanofi-Aventis U.S. LLC recalls Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.15 mg (a) 2 prefilled auto injectors + 1 trainer (NDC 0024-5831-02…

October 28, 2015 · Drug & medication recalls High risk Defective Delivery System; potential to have inaccurate dosage delivery